Literature DB >> 29168892

Functional properties of dopamine transporter oligomers after copper linking.

Juan Zhen1, Maarten E A Reith1,2.   

Abstract

Although it is universally accepted that dopamine transporters (DATs) exist in monomers, dimers and tetramers (i.e. dimers of dimers), it is not known whether the oligomeric organization of DAT is a prerequisite for its ability to take up dopamine (DA), or whether each DAT protomer, the subunit of quaternary structure, functions independently in terms of DA translocation. In this study, copper phenanthroline (CuP) was used to selectively target surface DAT: increasing concentrations of CuP gradually cross-linked natural DAT dimers in LLC-PK1 cells stably expressing hDAT and thereby reduced DA uptake functionality until all surface DATs were inactivated. DATs that were not cross-linked by CuP showed normal DA uptake with DA Km at ~ 0.5 μM and DA efflux with basal and amphetamine-induced DA efflux as much as control values. The cocaine analog 2β-carbomethoxy-3β-[4-fluorophenyl]-tropane (CFT) was capable to bind to copper-cross-linked DATs, albeit with an affinity more than fivefold decreased (Kd of CFT = 109 nM after cross-linking vs 19 nM before). A kinetic analysis is offered describing the changing amounts of dimers and monomers with increasing [CuP], allowing the estimation of dimer functional activity compared with a DAT monomer. Consonant with previous conclusions for serotonin transporter and NET that only one protomer of an oligomer is active at the time, the present data indicated a functional activity of the DAT dimer of 0.74 relative to a monomer.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  binding; cocaine analog; cross-linking; dopamine transporter oligomers; functional activity; protomers

Mesh:

Substances:

Year:  2017        PMID: 29168892      PMCID: PMC5760346          DOI: 10.1111/jnc.14259

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  35 in total

1.  Tracking single serotonin transporter molecules at the endoplasmic reticulum and plasma membrane.

Authors:  Andreas Anderluh; Enrico Klotzsch; Jonas Ries; Alexander W A F Reismann; Stefan Weber; Martin Fölser; Florian Koban; Michael Freissmuth; Harald H Sitte; Gerhard J Schütz
Journal:  Biophys J       Date:  2014-05-06       Impact factor: 4.033

2.  Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.

Authors:  Jun Zhu; Subbu Apparsundaram; Michael T Bardo; Linda P Dwoskin
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

3.  Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization.

Authors:  Mary Hongying Cheng; Jennie Garcia-Olivares; Steven Wasserman; Jennifer DiPietro; Ivet Bahar
Journal:  J Biol Chem       Date:  2017-06-05       Impact factor: 5.157

4.  Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Authors:  Mads Breum Larsen; Mark S Sonders; Ole Valente Mortensen; Gaynor A Larson; Nancy R Zahniser; Susan G Amara
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

5.  The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs.

Authors:  Hanne Hastrup; Namita Sen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

6.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

7.  Zn(2+) site engineering at the oligomeric interface of the dopamine transporter.

Authors:  Kristine Norgaard-Nielsen; Lene Norregaard; Hanne Hastrup; Jonathan A Javitch; Ulrik Gether
Journal:  FEBS Lett       Date:  2002-07-31       Impact factor: 4.124

8.  The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.

Authors:  Li-Bin Li; Nianhang Chen; Sammanda Ramamoorthy; Limen Chi; Xiao-Nan Cui; Lijuan C Wang; Maarten E A Reith
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

9.  A novel method for monitoring the cell surface expression of heteromeric protein complexes in dispersed neurons and acute hippocampal slices.

Authors:  David Holman; Jeremy M Henley
Journal:  J Neurosci Methods       Date:  2006-11-02       Impact factor: 2.390

10.  Direct PIP2 binding mediates stable oligomer formation of the serotonin transporter.

Authors:  Andreas Anderluh; Tina Hofmaier; Enrico Klotzsch; Oliver Kudlacek; Thomas Stockner; Harald H Sitte; Gerhard J Schütz
Journal:  Nat Commun       Date:  2017-01-19       Impact factor: 14.919

View more
  10 in total

1.  Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

Authors:  Mary Hongying Cheng; Luca Ponzoni; Tatiana Sorkina; Ji Young Lee; She Zhang; Alexander Sorkin; Ivet Bahar
Journal:  Neuropharmacology       Date:  2019-06-20       Impact factor: 5.250

Review 2.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

3.  Dopamine transporter oligomerization involves the scaffold domain, but spares the bundle domain.

Authors:  Kumaresan Jayaraman; Alex N Morley; Daniel Szöllősi; Tsjerk A Wassenaar; Harald H Sitte; Thomas Stockner
Journal:  PLoS Comput Biol       Date:  2018-06-06       Impact factor: 4.779

Review 4.  Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities.

Authors:  George R Uhl
Journal:  Ann Clin Transl Neurol       Date:  2019-01-08       Impact factor: 4.511

5.  Calbindin-D28K Limits Dopamine Release in Ventral but Not Dorsal Striatum by Regulating Ca2+ Availability and Dopamine Transporter Function.

Authors:  Katherine R Brimblecombe; Stefania Vietti-Michelina; Nicola J Platt; Rahel Kastli; Ahmad Hnieno; Caitlin J Gracie; Stephanie J Cragg
Journal:  ACS Chem Neurosci       Date:  2019-08-05       Impact factor: 4.418

6.  Effect of palmitoylation on the dimer formation of the human dopamine transporter.

Authors:  Talia Zeppelin; Kasper B Pedersen; Nils A Berglund; Xavier Periole; Birgit Schiøtt
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

7.  Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.

Authors:  Sarah Threlfell; Amir Saeid Mohammadi; Brent J Ryan; Natalie Connor-Robson; Nicola J Platt; Rishi Anand; Florence Serres; Trevor Sharp; Nora Bengoa-Vergniory; Richard Wade-Martins; Andrew Ewing; Stephanie J Cragg; Katherine R Brimblecombe
Journal:  Front Cell Neurosci       Date:  2021-04-15       Impact factor: 5.505

8.  Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter.

Authors:  Tatiana Sorkina; Shiqi Ma; Mads Breum Larsen; Simon C Watkins; Alexander Sorkin
Journal:  Elife       Date:  2018-04-09       Impact factor: 8.140

9.  Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent manner.

Authors:  Anand Kant Das; Oliver Kudlacek; Florian Baumgart; Kathrin Jaentsch; Thomas Stockner; Harald H Sitte; Gerhard J Schütz
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

Review 10.  SLC6 transporter oligomerization.

Authors:  Kumaresan Jayaraman; Anand K Das; Dino Luethi; Dániel Szöllősi; Gerhard J Schütz; Maarten E A Reith; Harald H Sitte; Thomas Stockner
Journal:  J Neurochem       Date:  2020-08-28       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.